SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio, a biotech company developing gene therapies for age-related diseases, today announced the appointments of Hugh Calkins, M.D., Stephen Chelko, Ph.D., and Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results